Cite

HARVARD Citation

    Rosmarin, D. et al. (2020). Ruxolitinib cream for treatment of vitiligo: a randomised, controlled, phase 2 trial. Lancet. 396 (10244), pp. 110-120. [Online]. 
  
Back to record